Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
09/1998
09/02/1998EP0861666A2 Pharmaceutical composition for use in treatment of diabetes
09/02/1998EP0861073A1 Stabilized thyroid hormone preparations and methods of making same
09/01/1998US5801190 Fused pyrrolo 2,3-C! carbazole-6-ones
09/01/1998US5801170 Heterocyclic biphenylylamides useful as 5HT1D antagonists
09/01/1998US5801159 Method and composition for inhibiting cellular irreversible changes due to stress
08/1998
08/27/1998WO1998037111A1 Transdermal pressure sensitive adhesive drug delivery system and pressure sensitive adhesive used therein
08/27/1998WO1998036769A1 Pulsatile delivery of leptin receptor ligands
08/27/1998WO1998036767A1 Modulation of the hypothalamic-pituitary-adrenal-adipose axis with leptin receptor ligands
08/27/1998WO1998036763A1 Treatment of infertility with leptin receptor ligands
08/27/1998WO1998036762A1 Method of modulating hypothalamic somatostatin release
08/27/1998WO1998029103A3 Use of calcium dobesilate for the manufacture of a medicament for the treatment of embryonic retardation
08/27/1998WO1998024802A3 Compound
08/27/1998CA2282341A1 Modulation of the hypothalamic-pituitary-adrenal-adipose axis with leptin receptor ligands
08/27/1998CA2282325A1 Pulsatile delivery of leptin receptor ligands
08/27/1998CA2282323A1 Method of modulating hypothalamic somatostatin release
08/27/1998CA2281888A1 Treatment of infertility with leptin receptor ligands
08/27/1998CA2276339A1 Transdermal pressure sensitive adhesive drug delivery system and pressure sensitive adhesive used therein
08/26/1998EP0859761A1 4-azasteroids for treatment of hyperandrogenic conditions
08/26/1998EP0859617A1 Method of preventing androgenetic alopecia with 5-alpha reductase inhibitors
08/26/1998EP0423326B1 Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient
08/26/1998CN1191475A Drug delivery compositions for improved stability of steroids
08/26/1998CN1191139A Liquid gonadotropin containing formulations
08/25/1998US5798347 Dehydroepiandrosterone and dehydroepiandrosterone sulfate used for inhibiting proliferation of ovarian cancer
08/25/1998US5798337 Low molecular weight peptidomimetic growth hormone secretagogues
08/25/1998CA2122479C Risedronate delayed-release compositions
08/20/1998WO1998035950A1 Benzofurazan compounds which enhance ampa receptor activity
08/19/1998EP0858508A1 Novel peptides useful in enhancement of fsh action
08/19/1998EP0858455A1 4-oxa and 4-thia steroids
08/19/1998EP0858442A1 4-phenyl-4-oxo-2-butenoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
08/19/1998EP0858338A1 Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use
08/19/1998EP0858337A2 A pharmaceutical composition for the treatment of autoimmune diseases
08/19/1998EP0858336A1 Method and pharmaceutical composition for regulating lipid concentration
08/18/1998US5795958 Library of glyco-peptides useful for identification of cell adhesion inhibitors
08/18/1998US5795957 Polypeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone
08/18/1998US5795905 CRF receptor antagonists and methods relating thereto
08/13/1998WO1998034947A1 ANTIGESTAGENIC STEROIDS WITH A FLUORINATED 17α-ALKYL CHAIN
08/13/1998WO1998034632A1 Compounds and compositions for delivering active agents
08/13/1998WO1998034621A1 Composition and method for supplementing testosterone in women with symptoms of testosterone deficiency
08/13/1998WO1998034583A2 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones
08/13/1998DE19706061A1 Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette Antiprogestin effective steroids with 17alpha-fluorinated alkyl chain
08/13/1998CA2280181A1 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones
08/13/1998CA2280033A1 Composition and method for supplementing testosterone in women with symptoms of testosterone deficiency
08/12/1998EP0857064A1 Stabilised pharmaceutical preparations containing thyroid hormone
08/12/1998EP0696275B1 Vitamin d amide derivatives
08/11/1998US5792772 Enatiomerically pure hydroxylated xanthine compounds
08/11/1998US5792764 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
08/06/1998WO1998027113A3 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5
08/05/1998EP0855917A1 Stable pharmaceutical forms of administration containing parathormone
08/04/1998US5789416 Cardiovascular and nervous system disorders
08/04/1998US5789405 Oxaspiro(2,5)octane derivative
08/04/1998US5788984 Gestodene-containing agent for transdermal administration
07/1998
07/30/1998WO1998032742A1 Novel amide derivatives and medicinal compositions thereof
07/30/1998WO1998032455A1 The extract of pine needle and the use thereof
07/30/1998CA2279261A1 The extract of pine needle and the use thereof
07/29/1998EP0854884A1 Ligand inhibitors of insulin-like growth factor binding proteins and methods of use therefor
07/29/1998EP0854715A1 Methods of inhibiting plasminogen activator inhibitor 1
07/29/1998CN1189166A Somatostatin peptides
07/29/1998CN1189101A Pharmaceutical combined preparation, kit and method for hormonal contraception
07/23/1998WO1998020906A3 Treatment of diabetes with transcription factor gene
07/22/1998EP0853945A1 Liquid gonadotropin containing formulations
07/22/1998EP0853610A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
07/22/1998CN1188414A Novel formulation for peptide release
07/22/1998CN1188411A Compressed dry-granulation desogestrel tablets
07/16/1998WO1998030590A2 Analogs of parathyroid hormone
07/16/1998WO1998030556A1 Novel benzofuranone derivatives and process for producing the same
07/16/1998WO1998019697A3 Novel pharmaceutical compositions
07/15/1998CA2226803A1 Liquid gonadotropin containing formulations
07/14/1998US5780648 Benzothiophene compounds, and uses formulations thereof
07/14/1998US5780460 Therapeutic methods and delivery systems utilizing sex steroid precursors
07/14/1998US5780050 Drug delivery compositions for improved stability of steroids
07/14/1998US5780014 Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
07/09/1998WO1998029103A2 Use of calcium dobesilate for the manufacture of a medicament for the treatment of embryonic retardation
07/09/1998WO1998005780A3 Voltage-gated calcium channel antagonist and methods
07/08/1998EP0851925A1 Human growth hormone variants
07/08/1998EP0851875A2 Dna sequences and secreted proteins encoded thereby
07/08/1998EP0851759A1 Compounds and methods
07/08/1998EP0851757A2 A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus
07/08/1998EP0672037B1 1,4-benzodiazepine derivatives and their use as cck-modulators
07/08/1998CN1187203A Method for treatment of corticosteroid induced osteopenia
07/08/1998CN1187120A Composition for sustained release of human growth hormone
07/07/1998US5776985 Cardiovascular disorders
07/07/1998US5776923 Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
07/07/1998US5776901 Polypeptide analogues having growth hormone releasing activity
07/07/1998US5776699 Method of identifying negative hormone and/or antagonist activities
07/01/1998EP0850221A1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
07/01/1998EP0850067A1 Method for treating cancers using 6- 3- 1-adamantyl]-4-hydroxyphenyl]
07/01/1998EP0850053A1 Erythrocytes loaded with s-nitrosothiol and uses therefor
07/01/1998CN1185950A Oral composition containing dehydroepiandrosterone and its sodium sulfate
06/1998
06/30/1998US5773032 Long-acting injection suspensions and a process for their preparation
06/25/1998WO1998027113A2 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5
06/25/1998WO1998026791A1 The use of a cimicifuga racemosa extract
06/25/1998CA2275442A1 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5
06/23/1998US5770687 Comformationally constrained backbone cyclized somatostatin analogs
06/23/1998US5770196 Modified antibody variable domains and therapeutic uses thereof
06/23/1998CA1339924C 11beta-phenyl-14betha steroids
06/18/1998WO1998025916A1 Novel benzopyran derivatives
06/18/1998WO1998018430A3 P2y receptor antagonists
06/17/1998EP0847755A1 Use of an extract of cimicifuga racemosa
06/17/1998EP0847402A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor
06/17/1998EP0847278A1 Analogs of parathyroid hormone